Medical Pharmacies Competitors and Similar CompaniesClear all

Medical Pharmacies's competitors and similar companies include Autobio Diagnostics, Ortho Clinical Diagnostics US, Transasia Bio-Medicals and Agilent Technologies.

	Medical Pharmacies Medical Pharmacies is a medical equipment supplier.	Autobio Diagnostics Autobio Diagnostics (奧託生物診斷有限公司) is a manufacturer and supplier of medical diagnostics products.	Ortho Clinical Diagnostics US Ortho Clinical Diagnostics US is a company specializing in in vitro diagnostics.	Transasia Bio-Medicals Transasia Bio-Medicals is a developer and manufacturer of healthcare products.	Agilent Technologies Agilent Technologies is a company that designs and manufactures laboratory instruments.
Founding Date	Founding Date 1957	Founding Date 1998	Founding Date 1994	Founding Date 1979	Founding Date 1999
Type	Type Private	Type Public	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics
Locations	Locations Markham, CA HQ	Locations Zheng Zhou Shi, CN HQ	Locations Raritan, US HQ Rochester, US	Locations HQ	Locations Santa Clara, US HQ Victoria, AU Wien, AT Zaventem, BE Barueri, BR Mississauga, CA Beijing, CN see more
Employees	Employees 199	Employees 5,773	Employees 1,650	Employees 2,0351% increase	Employees 18,0001% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 3.6 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 37.7 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥4.1b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $6.9b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ¥1.5b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $3.3b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ¥2.7b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $3.6b (FY, 2025)
Net income	Net income N/A	Net income ¥1.1b (FY, 2025)	Net income N/A	Net income N/A	Net income $1.3b (FY, 2025)